Brass EP - Search Results

1

Supplemental carnitine and exercise.

Brass EP. Brass EP. Am J Clin Nutr. 2000 Aug;72(2 Suppl):618S-23S. doi: 10.1093/ajcn/72.2.618S. Am J Clin Nutr. 2000. PMID: 10919968 Review.

2

Temporal pattern of skeletal muscle gene expression following endurance exercise in Alaskan sled dogs.

Brass EP, Peters MA, Hinchcliff KW, He YD, Ulrich RG. Brass EP, et al. J Appl Physiol (1985). 2009 Aug;107(2):605-12. doi: 10.1152/japplphysiol.91347.2008. Epub 2009 Jun 4. J Appl Physiol (1985). 2009. PMID: 19498091

3

Potential biomarkers of muscle injury after eccentric exercise.

Sietsema KE, Meng F, Yates NA, Hendrickson RC, Liaw A, Song Q, Brass EP, Ulrich RG. Sietsema KE, et al. Among authors: brass ep. Biomarkers. 2010 May;15(3):249-58. doi: 10.3109/13547500903502802. Biomarkers. 2010. PMID: 20028270

4

A systematic review and meta-analysis of propionyl-L-carnitine effects on exercise performance in patients with claudication.

Brass EP, Koster D, Hiatt WR, Amato A. Brass EP, et al. Vasc Med. 2013 Feb;18(1):3-12. doi: 10.1177/1358863X12467491. Epub 2013 Jan 15. Vasc Med. 2013. PMID: 23321261 Review.

5

Exercise capacity as a predictor of survival among ambulatory patients with end-stage renal disease.

Sietsema KE, Amato A, Adler SG, Brass EP. Sietsema KE, et al. Among authors: brass ep. Kidney Int. 2004 Feb;65(2):719-24. doi: 10.1111/j.1523-1755.2004.00411.x. Kidney Int. 2004. PMID: 14717947

6

The novel phosphodiesterase inhibitor NM-702 improves claudication-limited exercise performance in patients with peripheral arterial disease.

Brass EP, Anthony R, Cobb FR, Koda I, Jiao J, Hiatt WR. Brass EP, et al. J Am Coll Cardiol. 2006 Dec 19;48(12):2539-45. doi: 10.1016/j.jacc.2006.07.064. Epub 2006 Nov 28. J Am Coll Cardiol. 2006. PMID: 17174195 Clinical Trial.

7

Impact on carnitine homeostasis of short-term treatment with the pivalate prodrug cefditoren pivoxil.

Brass EP, Mayer MD, Mulford DJ, Stickler TK, Hoppel CL. Brass EP, et al. Clin Pharmacol Ther. 2003 Apr;73(4):338-47. doi: 10.1016/s0009-9236(02)17636-3. Clin Pharmacol Ther. 2003. PMID: 12709724 Clinical Trial.

8

Pivalate-generating prodrugs and carnitine homeostasis in man.

Brass EP. Brass EP. Pharmacol Rev. 2002 Dec;54(4):589-98. doi: 10.1124/pr.54.4.589. Pharmacol Rev. 2002. PMID: 12429869 Review.

9

Clinical and demographic predictors of exercise capacity in end-stage renal disease.

Sietsema KE, Hiatt WR, Esler A, Adler S, Amato A, Brass EP. Sietsema KE, et al. Among authors: brass ep. Am J Kidney Dis. 2002 Jan;39(1):76-85. doi: 10.1053/ajkd.2002.29884. Am J Kidney Dis. 2002. PMID: 11774105

10

Intermittent claudication: new targets for drug development.

Brass EP. Brass EP. Drugs. 2013 Jul;73(10):999-1014. doi: 10.1007/s40265-013-0078-3. Drugs. 2013. PMID: 23775528 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results